The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Almstead Neil Gregory since 2014.
This trader's CIK number is 1578850.
At the time of last reporting, Almstead Neil Gregory was the CHIEF TECHNICAL OPS OFFICER of Ptc Therapeutics, Inc.. (stock ticker symbol PTCT).
Also see all insider trading activities at Ptc Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PTCT | 0 | $0 | 5,925 | $281,300 | 0 | $0 |
| 2024 | PTCT | 0 | $0 | 72,256 | $3,763,737 | 71,610 | $3,652,110 |
| 2023 | PTCT | 0 | $0 | 2,327 | $101,292 | 0 | $0 |
| 2022 | PTCT | 0 | $0 | 1,540 | $60,463 | 0 | $0 |
| 2021 | PTCT | 0 | $0 | 107,506 | $6,544,639 | 105,338 | $1,799,961 |
| 2020 | PTCT | 0 | $0 | 79,246 | $4,474,109 | 74,062 | $812,716 |
| 2019 | PTCT | 0 | $0 | 653 | $22,691 | 0 | $0 |
| 2018 | PTCT | 0 | $0 | 20,780 | $979,535 | 20,000 | $217,000 |
| 2017 | PTCT | 0 | $0 | 78 | $921 | 0 | $0 |
| 2016 | PTCT | 0 | $0 | 0 | $0 | 10,000 | $108,500 |
| 2015 | PTCT | 0 | $0 | 59,960 | $3,894,576 | 30,000 | $325,499 |
| 2014 | PTCT | 0 | $0 | 11,034 | $356,835 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-19 | PTCT | Sale | 1,334 | 50.10 | 66,828 |
| 2025-02-20 | PTCT | Sale | 1,612 | 50.12 | 80,799 |
| 2025-01-07 | PTCT | Sale | 1,320 | 45.34 | 59,848 |
| 2025-01-08 | PTCT | Sale | 1,659 | 44.50 | 73,825 |
| 2024-12-02 | PTCT | Option Ex | 71,610 | 51.00 | 3,652,110 |
| 2024-12-02 | PTCT | Sale | 71,610 | 52.31 | 3,746,133 |
| 2024-01-30 | PTCT | Sale | 646 | 27.25 | 17,604 |
| 2023-01-31 | PTCT | Sale | 658 | 45.63 | 30,023 |
| 2023-01-11 | PTCT | Sale | 410 | 44.36 | 18,187 |
| 2023-01-10 | PTCT | Sale | 500 | 42.93 | 21,466 |
| 2023-01-09 | PTCT | Sale | 759 | 41.66 | 31,616 |
| 2022-02-01 | PTCT | Sale | 632 | 40.00 | 25,281 |
| 2022-01-25 | PTCT | Sale | 43 | 39.31 | 1,690 |
| 2022-01-07 | PTCT | Sale | 801 | 38.52 | 30,858 |
| 2022-01-04 | PTCT | Sale | 64 | 41.16 | 2,634 |
| 2021-02-01 | PTCT | Sale | 1,001 | 56.96 | 57,012 |
| 2021-01-25 | PTCT | Sale | 541 | 62.65 | 33,894 |
| 2021-01-08 | PTCT | Option Ex | 1,300 | 27.05 | 35,165 |
| 2021-01-08 | PTCT | Sale | 1,300 | 69.00 | 89,700 |
| 2021-01-05 | PTCT | Sale | 626 | 62.37 | 39,043 |
| 2021-01-04 | PTCT | Option Ex | 104,038 | 16.96 | 1,764,796 |
| 2021-01-04 | PTCT | Sale | 104,038 | 60.80 | 6,324,990 |
| 2020-11-04 | PTCT | Option Ex | 24,062 | 11.23 | 270,216 |
| 2020-11-04 | PTCT | Sale | 24,062 | 60.00 | 1,443,720 |
| 2020-02-06 | PTCT | Option Ex | 50,000 | 10.85 | 542,500 |
| 2020-02-05 | PTCT | Sale | 405 | 55.00 | 22,275 |
| 2020-02-06 | PTCT | Sale | 54,040 | 55.00 | 2,972,200 |
| 2020-01-23 | PTCT | Sale | 46 | 53.25 | 2,449 |
| 2020-01-07 | PTCT | Sale | 59 | 49.62 | 2,927 |
| 2020-01-06 | PTCT | Sale | 634 | 48.17 | 30,538 |
| 2019-01-07 | PTCT | Sale | 653 | 34.75 | 22,691 |
| 2018-06-19 | PTCT | Option Ex | 20,000 | 10.85 | 217,000 |
| 2018-06-19 | PTCT | Sale | 20,000 | 48.27 | 965,500 |
| 2018-01-05 | PTCT | Sale | 703 | 18.03 | 12,675 |
| 2018-01-04 | PTCT | Sale | 77 | 17.67 | 1,360 |
| 2017-01-05 | PTCT | Sale | 78 | 11.82 | 921 |
| 2016-09-27 | PTCT | Option Ex | 10,000 | 10.85 | 108,500 |
| 2015-04-15 | PTCT | Sale | 9,511 | 68.69 | 653,358 |
| 2015-03-19 | PTCT | Sale | 20,370 | 70.85 | 1,443,255 |
| 2015-03-10 | PTCT | Sale | 79 | 70.71 | 5,586 |
| 2015-02-17 | PTCT | Option Ex | 3,904 | 10.85 | 42,358 |
| 2015-02-17 | PTCT | Sale | 3,904 | 53.97 | 210,679 |
| 2015-01-21 | PTCT | Sale | 996 | 60.00 | 59,760 |
| 2015-01-20 | PTCT | Sale | 25,100 | 60.63 | 1,521,938 |
| 2015-01-21 | PTCT | Option Ex | 996 | 10.85 | 10,806 |
| 2015-01-20 | PTCT | Option Ex | 25,100 | 10.85 | 272,335 |
| 2014-12-04 | PTCT | Sale | 175 | 50.00 | 8,750 |
| 2014-03-19 | PTCT | Sale | 10,859 | 32.05 | 348,085 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER of Ptc Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.